Madrigal Pharmaceuticals, Inc.

This study is testing whether an oral medication called resmetirom can reduce harmful fat buildup in the liver of people who have had a liver transplant. It will involve 120 participants who have developed fatty liver disease after their transplant. The main goal is to see if the…